HAO

Revenue: US$24.0m (up 1.9% from 1H 2024). Revenue: US$24.0m (up 1.9% from 1H 2024). Net loss: US$232.5k (down by 131% from US$760.2k profit in 1H 2024). Net loss: US$232.5k (down by 131% from US$760.2k profit in 1H 2024). US$0.13 loss per share (down from US$0.65 profit in 1H 2024). US$0.13 loss per share (down from US$0.65 profit in 1H 2024). We've discovered 5 warning signs about Haoxi Health Technology. View them for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Haoxi Health Technology shares are up 31% from a week ago. Before you take the next step you should know about the 5 warning signs for Haoxi Health Technology (4 are a bit concerning!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.